3 Claims Of Schering's Zetia Patent Found Invalid
The federal judge overseeing Schering-Plough Corp.'s suit to block Glenmark Pharmaceuticals Inc. from making a generic version of anti-cholesterol treatment Zetia has ruled that three claims of Schering's asserted patent are...To view the full article, register now.
Already a subscriber? Click here to view full article